enprofylline has been researched along with Angiogenesis, Pathologic in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mino, RP | 1 |
| Spoerri, PE | 1 |
| Caballero, S | 1 |
| Player, D | 1 |
| Belardinelli, L | 1 |
| Biaggioni, I | 1 |
| Grant, MB | 1 |
1 other study available for enprofylline and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Adenosine receptor antagonists and retinal neovascularization in vivo.
Topics: Angiography; Animals; Animals, Newborn; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pu | 2001 |